Free Trial

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

Senseonics Holdings, Inc. Common Stock logo
$9.80 -0.16 (-1.61%)
As of 10:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.

SENS vs. ATEC, OMCL, CNMD, DRTS, and IART

Should you buy Senseonics Holdings, Inc. Common Stock stock or one of its competitors? Senseonics Holdings, Inc. Common Stock's main competitors and comparable companies include Alphatec (ATEC), Omnicell (OMCL), CONMED (CNMD), Alpha Tau Medical (DRTS), and Integra LifeSciences (IART). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Senseonics Holdings, Inc. Common Stock compare to Alphatec?

Alphatec (NASDAQ:ATEC) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

Alphatec has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market.

Alphatec has a net margin of -13.49% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Senseonics Holdings, Inc. Common Stock's return on equity of -165.80% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Alphatec-13.49% -6,752.24% -13.88%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

Alphatec presently has a consensus price target of $17.40, indicating a potential upside of 65.09%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 72.69%. Given Senseonics Holdings, Inc. Common Stock's higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Alphatec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec
1 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.80
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alphatec$764.16M2.13-$143.36M-$0.71N/A
Senseonics Holdings, Inc. Common Stock$35.26M11.81-$69.11M-$2.23N/A

66.4% of Alphatec shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Alphatec had 1 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 5 mentions for Alphatec and 4 mentions for Senseonics Holdings, Inc. Common Stock. Alphatec's average media sentiment score of 0.52 beat Senseonics Holdings, Inc. Common Stock's score of 0.33 indicating that Alphatec is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alphatec
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Alphatec beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Omnicell?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Omnicell (NASDAQ:OMCL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 97.7% of Omnicell shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Comparatively, 2.9% of Omnicell shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Senseonics Holdings, Inc. Common Stock and Senseonics Holdings, Inc. Common Stock both had 4 articles in the media. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.33 beat Omnicell's score of 0.25 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Omnicell
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Omnicell has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics Holdings, Inc. Common Stock$35.26M11.81-$69.11M-$2.23N/A
Omnicell$1.18B1.36$2.05M$0.8442.21

Senseonics Holdings, Inc. Common Stock presently has a consensus price target of $17.20, indicating a potential upside of 72.69%. Omnicell has a consensus price target of $57.86, indicating a potential upside of 63.16%. Given Senseonics Holdings, Inc. Common Stock's higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Omnicell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Omnicell
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78

Omnicell has a net margin of 3.13% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Omnicell's return on equity of 5.66% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Senseonics Holdings, Inc. Common Stock-225.09% -165.80% -80.14%
Omnicell 3.13%5.66%3.57%

Senseonics Holdings, Inc. Common Stock has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market. Comparatively, Omnicell has a beta of 0.98, suggesting that its stock price is 2% less volatile than the broader market.

Summary

Omnicell beats Senseonics Holdings, Inc. Common Stock on 10 of the 15 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to CONMED?

CONMED (NYSE:CNMD) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

CONMED has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CONMED$1.37B0.97$47.06M$1.8523.98
Senseonics Holdings, Inc. Common Stock$35.26M11.81-$69.11M-$2.23N/A

CONMED has a net margin of 4.12% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. CONMED's return on equity of 14.31% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
CONMED4.12% 14.31% 6.33%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

CONMED presently has a consensus price target of $41.40, suggesting a potential downside of 6.69%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, suggesting a potential upside of 72.69%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than CONMED.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CONMED
1 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.88
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 0.3% of CONMED shares are held by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CONMED has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.02, indicating that its share price is 2% more volatile than the broader market.

In the previous week, Senseonics Holdings, Inc. Common Stock had 1 more articles in the media than CONMED. MarketBeat recorded 4 mentions for Senseonics Holdings, Inc. Common Stock and 3 mentions for CONMED. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.33 beat CONMED's score of 0.23 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CONMED
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Senseonics Holdings, Inc. Common Stock beats CONMED on 9 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTS) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

Alpha Tau Medical has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.02, suggesting that its stock price is 2% more volatile than the broader market.

Alpha Tau Medical has higher earnings, but lower revenue than Senseonics Holdings, Inc. Common Stock. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
Senseonics Holdings, Inc. Common Stock$35.26M11.81-$69.11M-$2.23N/A

In the previous week, Senseonics Holdings, Inc. Common Stock had 2 more articles in the media than Alpha Tau Medical. MarketBeat recorded 4 mentions for Senseonics Holdings, Inc. Common Stock and 2 mentions for Alpha Tau Medical. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.33 beat Alpha Tau Medical's score of 0.05 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Tau Medical currently has a consensus target price of $15.40, indicating a potential upside of 6.35%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, indicating a potential upside of 72.69%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Alpha Tau Medical has a net margin of 0.00% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Alpha Tau Medical's return on equity of -138.12% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Senseonics Holdings, Inc. Common Stock beats Alpha Tau Medical on 8 of the 15 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Integra LifeSciences?

Integra LifeSciences (NASDAQ:IART) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Integra LifeSciences presently has a consensus price target of $17.29, indicating a potential upside of 29.77%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 72.69%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
2 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.88
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Integra LifeSciences had 28 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 32 mentions for Integra LifeSciences and 4 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.33 beat Integra LifeSciences' score of 0.00 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
2 Very Positive mention(s)
2 Positive mention(s)
13 Neutral mention(s)
11 Negative mention(s)
0 Very Negative mention(s)
Neutral
Senseonics Holdings, Inc. Common Stock
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Integra LifeSciences has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.02, meaning that its stock price is 2% more volatile than the broader market.

Integra LifeSciences has a net margin of -0.44% compared to Senseonics Holdings, Inc. Common Stock's net margin of -225.09%. Integra LifeSciences' return on equity of 18.30% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences-0.44% 18.30% 5.30%
Senseonics Holdings, Inc. Common Stock -225.09%-165.80%-80.14%

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.64B0.63-$516.47M-$0.09N/A
Senseonics Holdings, Inc. Common Stock$35.26M11.81-$69.11M-$2.23N/A

Summary

Integra LifeSciences and Senseonics Holdings, Inc. Common Stock tied by winning 8 of the 16 factors compared between the two stocks.

Get Senseonics Holdings, Inc. Common Stock News Delivered to You Automatically

Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SENS vs. The Competition

MetricSenseonics Holdings, Inc. Common StockHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$409.64M$5.46B$7.19B$13.31B
Dividend YieldN/A1.78%2.53%17.39%
P/E Ratio-4.3925.36274.2526.19
Price / Sales11.6282.48640.77107.86
Price / CashN/A32.4579.4153.24
Price / Book6.585.9710.826.28
Net Income-$69.11M$146.97M$3.50B$381.84M
7 Day Performance-3.64%0.00%-2.38%-1.21%
1 Month Performance1.77%-4.73%-7.36%-5.59%
1 Year PerformanceN/A1.78%5.44%0.59%

Senseonics Holdings, Inc. Common Stock Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SENS
Senseonics Holdings, Inc. Common Stock
3.3362 of 5 stars
$9.80
-1.6%
$13.00
+32.7%
N/A$409.64M$35.26MN/A130
ATEC
Alphatec
3.6672 of 5 stars
$10.32
-0.5%
$17.40
+68.6%
-22.5%$1.60B$764.16MN/A913
OMCL
Omnicell
3.8725 of 5 stars
$34.05
-0.8%
$57.86
+69.9%
+16.2%$1.56B$1.18B40.543,580
CNMD
CONMED
2.0488 of 5 stars
$46.26
-0.9%
$41.40
-10.5%
-4.4%$1.40B$1.37B25.003,900
DRTS
Alpha Tau Medical
1.5605 of 5 stars
$14.91
-1.8%
$15.40
+3.3%
+243.1%$1.37BN/AN/A121

Related Companies and Tools


This page (NASDAQ:SENS) was last updated on 10/7/2026 by MarketBeat.com Staff.
From Our Partners